STADA Arzneimittel AG — M&A Activity 2007

Sep 21, 2007

News Details

Ad-hoc | 21 September 2007 13:40

STADA: Acquisition of the British Forum Bioscience successfully completed

STADA Arzneimittel AG / Acquisition

Release of an Ad-hoc-update according to § 15 WpHG, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

STADA has today, on September 21, 2007, successfully completed the
acquisition of the British pharmaceutical group Forum Bioscience Holdings
Ltd. through subsidiaries after all contractual agreements necessary for
the completion of the acquisition had been implemented and the approval of
the anti-trust authorities was given (see ad hoc release from August 31,
2007, published via the DGAP).

The Forum Bioscience Group will be consolidated in the STADA Group as of
October 1, 2007.

Further information:
STADA Arzneimittel AG / Corporate Communications / Stadastraße 2–18 /
61118 Bad Vilbel, Germany / Phone: +49(0) 6101 603-113 /
Fax: +49(0) 6101 603-506 / E-mail: communications@stada.de
Or visit our website at www.stada.com
21.09.2007 Financial News transmitted by DGAP

---

Language: English
Issuer: STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Deutschland
Phone: +49 (0)6101 603- 113
Fax: +49 (0)6101 603- 506
E-mail: communications@stada.de
Internet: www.stada.de
ISIN: DE0007251803, DE0007251845,
WKN: 725180, 725184,
Indices: MDAX
Listed: Amtlicher Markt in Frankfurt (Prime Standard), Düsseldorf;
Freiverkehr in Berlin, Hannover, Hamburg, München, Stuttgart

End of News DGAP News-Service

---